xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

395

ICAR SINONASAL TUMORS

453. Hasan OK, Ravi Kumar AS, Kong G, et al. Efficacy of peptide receptor radionuclide therapy for esthesioneurob lastoma. JNuclMed . 2020;61(9):1326-1330. https://doi.org/10. 2967/jnumed.119.237990 454. Homma A, Sakashita T, Yoshida D, et al. Superselective intra arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer. Br J Cancer . 2013;109(12):2980-2986. https://doi.org/10.1038/bjc.2013.663 455. Jiang W, Mohamed ASR, Fuller CD, et al. The role of elec tive nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol . 2016;6(4):241-247. https://doi.org/10.1016/j.prro.2015.10.023 456. Yin Z-z, Luo J-w, Gao L, et al. Spread patterns of lymph nodes and the value of elective neck irradiation for esthesioneurob lastoma. Radiother Oncol . 2015;117(2):328-332. https://doi.org/ 10.1016/j.radonc.2015.10.002 457. Song X, Huang C, Wang S, Yan L, Wang J, Li Y. Neck manage ment in patients with olfactory neuroblastoma. Oral Oncol . 2020;101:104505. https://doi.org/10.1016/j.oraloncology.2019. 104505 458. Patel SH, Wang Z, Wong WW, et al. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncology . 2014;15(9):1027-1038. https://doi.org/10.1016/ S1470-2045(14)70268-2 459. Hoppe BS, Wolden SL, Zelefsky MJ, et al. Postopera tive intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity. Head Neck . 2008;30(7):925-932. https://doi.org/10.1002/hed.20800 460. Dagan R, Uezono H, Bryant C, Holtzman AL, Morris CG, Mendenhall WM. Long-term outcomes from proton ther apy for sinonasal cancers. Int J Part Ther . 2021;8(1):200-212. https://doi.org/10.14338/IJPT-20-00068.1 461. Aljabab S, Lui A, Wong T, Liao J, Laramore G, Parvathaneni U. A combined neutron and proton regimen for advanced salivary tumors: early clinical experience. Cureus . 2021;13(5):e14844. https://doi.org/10.7759/cureus.14844 462. Al-Mamgani A, Monserez D, van Rooij P, Verduijn GM, Hardillo JAU, Levendag PC. Highly-conformal intensity-modulated radiotherapy reduced toxicity with out jeopardizing outcome in patients with paranasal sinus cancer treated by surgery and radiotherapy or (chemo)radiation. Oral Oncol . 2012;48(9):905-911. https://doi.org/10.1016/j.oraloncology.2012.03.024 463. Douglas JG, Koh W-j, Austin-Seymour M, Laramore GE. Treatment of salivary gland neoplasms with fast neu tron radiotherapy. Arch Otolaryngol Head Neck Surg . 2003;129(9):944-948. https://doi.org/10.1001/archotol.129.9. 944 464. Duprez F, Madani I, Morbée L, et al. IMRT for sinonasal tumors minimizes severe late ocular toxicity and pre serves disease control and survival. Int J Radiat Oncol Biol Phys . 2012;83(1):252-259. https://doi.org/10.1016/j.ijrobp.2011. 06.1977 465. Filtenborg MV, Lilja-Fischer JK, Sharma MB, et al. Sinonasal cancer in Denmark 2008–2015: a population-based phase-4 cohort study from DAHANCA. Acta Oncol . 2021;60(3):333 342. https://doi.org/10.1080/0284186x.2021.1874618

cies. Sci Rep . 2019;9(1):4259. https://doi.org/10.1038/s41598 019-39241-y 440. Gogineni E, Zhang I, Rana Z, et al. Quality of life outcomes following organ-sparing SBRT in previously irradiated recur rent head and neck cancer. Front Oncol . 2019;9:836. https:// doi.org/10.3389/fonc.2019.00836 441. Hayashi K, Koto M, Ikawa H, et al. Feasibility of Re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy. Radiother Oncol . 2019;136:148 153. https://doi.org/10.1016/j.radonc.2019.04.007 442. Fan M, Kang JJ, Lee A, et al. Outcomes and toxicities of defini tive radiotherapy and reirradiation using 3-dimensional con formal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignan cies. Cancer . 2020;126(9):1905-1916. https://doi.org/10.1002/ cncr.32776 443. Bahig H, Ng SP, Pollard C, et al. A prospective evaluation of health-related quality of life after skull base re-irradiation. Head Neck . 2020;42(3):485-497. https://doi.org/10.1002/hed. 26037 444. Yamazaki H, Suzuki G, Aibe N, et al. Reirradia tion for nasal cavity or paranasal sinus tumor—a multi-institutional study. Cancers . 2021;13(24):6315. https://doi.org/10.3390/cancers13246315 445. Firlik KS, Kondziolka D, Lunsford LD, Janecka IP, Flickinger JC. Radiosurgery for recurrent cranial base cancer arising from the head and neck. Head Neck . 1996;18(2):160-165; dis cussion 166. https://doi.org/10.1002/(SICI)1097-0347(199603/ 04)18:2 ⟨ 160::AID-HED8 ⟩ 3.0.CO;2-# 446. Pollock BE, Iuliano BA, Foote RL, Gorman DA. Stereotac tic radiosurgery for tumor-related trigeminal pain. Neuro surgery . 2000;46(3):576-582; discussion 582-583. https://doi. org/10.1097/00006123-200003000-00010 447. Kano H, Niranjan A, Kondziolka D, Flickinger JC, Lunsford LD. The role of palliative radiosurgery when cancer invades the cavernous sinus. Int J Radiat Oncol Biol Phys . 2009;73(3):709-715. https://doi.org/10.1016/j.ijrobp.2008.05. 005 448. Clump DA, Leeman JE, Wegner RE, Burton SA, Mintz AH, Heron DE. Stereotactic radiosurgery for the treatment and palliation of base of skull metastases. J Radiosurg SBRT . 2013;2(3):217-223. 449. Dröge LH, Hinsche T, Canis M, Alt-Epping B, Hess CF, Wolff HA. Fractionated external beam radiotherapy of skull base metastases with cranial nerve involvement. Strahlenther Onkol . 2014;190(2):199-203. https://doi.org/10.1007/s00066 013-0460-9 450. Phan J, Pollard C, Brown PD, et al. Stereotactic radiosurgery for trigeminal pain secondary to recurrent malignant skull base tumors. J Neurosurg . 2018;130(3):812-821. https://doi.org/ 10.3171/2017.11.JNS172084 451. Chan JYW, To VSH, Wong STS, Wei WI. Quality of dying in head and neck cancer patients: the role of surgical pallia tion. Eur Arch Otorhinolaryngol . 2013;270(2):681-688. https:// doi.org/10.1007/s00405-012-2059-7 452. Farber NI, Povolotskiy R, Bavier RD, Riccardi J, Eloy JA, Hsueh WD. Impact of palliative treatment on sur vival in sinonasal malignancies. Int Forum Allergy Rhinol . 2019;9(12):1499-1507. https://doi.org/10.1002/alr.22432